Skip to content

BRIGHT-study

Establishing reference values for assessing breast skin perfusion with quantified fluorescence angiography - BRIGHT study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58084
Enrollment
53
Registered
2025-08-12
Start date
2025-12-30
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer, skin flap necrosis Breast cancer, skin tissue death

Interventions

Quantified fluorescence angiography using indocyanine green.

Sponsors

Medisch Spectrum Twente (MST)
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Female patients scheduled to undergo breast-conserving surgery or mastectomy for benign or malignant breast lesions. 

Exclusion criteria

Exclusion criteria: Bilateral breast malignancy.History of surgery or radiation therapy on or around the thorax.Previous surgery on the contralateral breast (with respect to the tumor). Signs of active or recent inflammation/infection of the breast skin. Pregnancy or breastfeeding.History of systemic microvascular disease (e.g. Raynaud's disease, diabetic microangiopathy).Current use of vasoconstrictive medication. Contra-indications for ICG: Known allergy or hypersensitivity for ICG or iodine. Severely impaired renal function (estimated globular filtration rate < 15).Hyperthyroidism.

Design outcomes

Primary

MeasureTime frame
Quantified perfusion parameters of healthy breast skin measured with indocyanine green fluorescence angiography. These parameters are the time-to-peak (unit = seconds) and maximal slope (unit = arbitrary units / second), extracted from fluorescent intensity-over-time curves.  

Secondary

MeasureTime frame
It is assumed that perfusion in the breast is heterogeneous; the different quadrants and the nipple–areola complex are supplied by distinct blood vessels and perforators. Consequently, normal perfusion values can vary between regions, even in healthy (non-operated) breasts. Segmental analysis can be used to establish regional reference values, which is essential for the accurate interpretation of perfusion in clinical applications, such as predicting wound healing or necrosis after mastectomy. 1. Q-FA perfusion parameters, measured specifically in the areola. 2. Q-FA parameters, measured specifically in the 4 anatomical quadrants of the breast (i.e. upper lateral, upper medial, lower lateral and lower medial). 3. Cardiovascular risk factors: BMI, smoking history, diabetes, hypertension, hyperlipidaemia. 4.Intraoperative physiological parameters: blood pressure, ventilation parameters, patient positioning.

Countries

Netherlands

Contacts

Public ContactA. Christenhusz

Medisch Spectrum Twente (MST)

anke.christenhusz@mst.nl053 487 2000

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Feb 7, 2026